| Literature DB >> 26405219 |
Chunsheng Li1, Armin Ansari2, Christine Bartizel3, Paolo Battisti4, Didier Franck3, Udo Gerstmann5, Isabella Giardina4, Claude Guichet6, Derek Hammond7, Martina Hartmann5, Robert L Jones2, Eunjoo Kim8, Raymond Ko9, Ryan Morhard10, Deborah Quayle9, Baki Sadi9, David Saunders2, Francois Paquet3.
Abstract
The Global Health Security Initiative (GHSI) established a laboratory network within the GHSI community to develop their collective surge capacity for radionuclide bioassay in response to a radiological or nuclear emergency. A recent exercise was conducted to test the participating laboratories for their capabilities in screening and in vitro assay of biological samples, performing internal dose assessment and providing advice on medical intervention, if necessary, using a urine sample spiked with a single radionuclide, 241Am. The laboratories were required to submit their reports according to the exercise schedule and using pre-formatted templates. Generally, the participating laboratories were found to be capable with respect to rapidly screening samples for radionuclide contamination, measuring the radionuclide in the samples, assessing the intake and radiation dose, and providing advice on medical intervention. However, gaps in bioassay measurement and dose assessment have been identified. The network may take steps to ensure that procedures and practices within this network be harmonised and a follow-up exercise be organised on a larger scale, with potential participation of laboratories from the networks coordinated by the International Atomic Energy Agency and the World Health Organization.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26405219 PMCID: PMC5723925 DOI: 10.1093/rpd/ncv386
Source DB: PubMed Journal: Radiat Prot Dosimetry ISSN: 0144-8420 Impact factor: 0.972